Fischer JC, Schmidt AG, Bölke E, Keitel V, Feldt T, Jensen B, Freise NF, Häussinger D, Schneider EM, Hermsen D, Kindgen-Milles D, Knoefel WT, Haussmann J, Tamaskovics B, Plettenberg C, Scheckenbach K, Corradini S, Rox J, Balz V, Maas K, Schmidt L, Grebe O, Erhardt A, Gerber PA, Peiper M, Buhren BA, Lichtenberg A, Rezazadeh A, Budach W, Matuschek C (2021)
Publication Type: Journal article
Publication year: 2021
Book Volume: 26
Article Number: 87
Journal Issue: 1
DOI: 10.1186/s40001-021-00558-y
Background: COVID-19 infection is a major threat to patients and health care providers around the world. One solution is the vaccination against SARS-CoV-2. Methods: We performed a comprehensive query of the latest publications on the prevention of viral infections including the recent vaccination program and its side effects. Results: The situation is evolving rapidly and there is no reasonable alternative to population-scale vaccination programs as currently enrolled. Conclusion: Therefore, regulatory authorities should consider supplementing their conventional mandate of post-approval pharmacovigilance, which is based on the collection, assessment, and regulatory response to emerging safety findings.
APA:
Fischer, J.C., Schmidt, A.G., Bölke, E., Keitel, V., Feldt, T., Jensen, B.,... Matuschek, C. (2021). Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing. European Journal of Medical Research, 26(1). https://doi.org/10.1186/s40001-021-00558-y
MLA:
Fischer, Johannes C., et al. "Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing." European Journal of Medical Research 26.1 (2021).
BibTeX: Download